MARENGONI, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 10.718
EU - Europa 3.907
AS - Asia 2.056
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 20
OC - Oceania 17
AF - Africa 16
Totale 16.755
Nazione #
US - Stati Uniti d'America 10.686
UA - Ucraina 1.367
CN - Cina 1.242
IT - Italia 576
DE - Germania 484
HK - Hong Kong 473
PL - Polonia 447
FI - Finlandia 292
SG - Singapore 257
IE - Irlanda 256
GB - Regno Unito 239
FR - Francia 122
IN - India 30
CA - Canada 26
SE - Svezia 22
CZ - Repubblica Ceca 20
EU - Europa 20
RU - Federazione Russa 19
TR - Turchia 16
AU - Australia 15
BE - Belgio 15
NL - Olanda 13
VN - Vietnam 13
MU - Mauritius 10
BR - Brasile 8
ES - Italia 7
KR - Corea 6
JP - Giappone 5
RO - Romania 5
CO - Colombia 4
EE - Estonia 4
PT - Portogallo 4
AR - Argentina 3
GR - Grecia 3
IR - Iran 3
MX - Messico 3
NO - Norvegia 3
PE - Perù 3
BG - Bulgaria 2
EC - Ecuador 2
MA - Marocco 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
SA - Arabia Saudita 2
AT - Austria 1
AZ - Azerbaigian 1
CL - Cile 1
CU - Cuba 1
DK - Danimarca 1
EG - Egitto 1
GE - Georgia 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
OM - Oman 1
PA - Panama 1
PK - Pakistan 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TW - Taiwan 1
UG - Uganda 1
ZA - Sudafrica 1
Totale 16.755
Città #
Fairfield 1.831
Woodbridge 1.321
Jacksonville 1.049
Houston 804
Ashburn 802
Cambridge 707
Seattle 690
Wilmington 674
Ann Arbor 663
Princeton 490
Hong Kong 472
Warsaw 444
Chandler 376
Nanjing 319
Dublin 256
New York 196
Beijing 189
Singapore 161
Helsinki 152
Dearborn 127
Brescia 123
Nanchang 116
Des Moines 107
San Diego 94
Shenyang 87
Changsha 85
Hebei 66
Milan 64
Jiaxing 55
Lancaster 55
Tianjin 54
Shanghai 46
Kunming 42
London 42
Jinan 30
Verona 26
Toronto 22
San Francisco 21
Rome 19
Guangzhou 17
Brno 16
Lanzhou 16
Ningbo 16
Brussels 15
Zhengzhou 15
Hangzhou 14
Orange 14
Norwalk 13
Boardman 12
Dong Ket 12
Kilburn 12
Fuzhou 10
Changchun 9
Lappeenranta 9
Taizhou 9
Hefei 8
Kocaeli 8
Napoli 8
Taiyuan 8
Torino 7
Perugia 6
Canberra 5
Chicago 5
Comun Nuovo 5
Genoa 5
Gunzenhausen 5
Haikou 5
Hanover 5
Hounslow 5
Indiana 5
Islington 5
Munich 5
Parma 5
Redmond 5
Sydney 5
Bergamo 4
Bologna 4
Cremona 4
Isorella 4
Lissone 4
Melbourne 4
New Bedfont 4
Olomouc 4
Palermo 4
Paris 4
Southwark 4
São Paulo 4
Tallinn 4
Turin 4
Acton 3
Chiswick 3
Falls Church 3
Frankfurt am Main 3
Imagocho 3
Lima 3
Los Angeles 3
Mussomeli 3
Nürnberg 3
Oslo 3
Prescot 3
Totale 13.290
Nome #
C-reactive protein, lipoprotein (a) and cystatin C levels increase with multimorbidity in older persons 267
VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients 266
AGING AND MULTIMORBIDITY: ASSOCIATIONS WITH INFLAMMATORY BIOMARKERS 249
Social networks and health status in the elderly: the ‘ANZIANI IN-RETE’ population-based study 160
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 153
Heart failure and chronic kidney disease in a registry of internal medicine wards 149
"Delirium Day": A nationwide point prevalence study of delirium in older hospitalized patients using an easy standardized diagnostic tool 144
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 135
Accounting for frailty when treating chronic diseases 123
Drug Prescription and Delirium in Older Inpatients: Results From the Nationwide Multicenter Italian Delirium Day 2015-2016 122
Frailty predicts short-term survival even in older adults without multimorbidity 120
Association Between Human Parainfluenza Virus Type 1 and Smoking History in Patients With an Abdominal Aortic Aneurysm 118
Trajectories of functional decline in older adults with neuropsychiatric and cardiovascular multimorbidity: A Swedish cohort study 116
The Effect of a 2-Year Intervention Consisting of Diet, Physical Exercise, Cognitive Training, and Monitoring of Vascular Risk on Chronic Morbidity-the FINGER Randomized Controlled Trial 116
Strategies to Improve Medication Adherence in Older Persons: Consensus Statement from the Senior Italia Federanziani Advisory Board 115
Using an Integrated Clinical and Functional Assessment Tool to Describe the Use of Social and Medical Care in an Urban Community-Dwelling Swedish Older Population 115
Mental health and the global agenda. 114
Potentially Serious Drug-Drug Interactions in Older Patients Hospitalized for Acute Ischemic and Hemorrhagic Stroke 114
A 20-Year Clinical and Pathological Evolution of Idiopathic Cerebral Calcinosis. 112
Effect of Chronic Diseases and Multimorbidity on Survival and Functioning in Elderly Adults 112
Rapidly developing multimorbidity and disability in older adults: does social background matter? 109
Advanced Age and Medication Prescription: More Years, Less Medications? A Nationwide Report From the Italian Medicines Agency 107
Toward appropriate criteria in medication adherence assessment in older persons: Position Paper 107
Drug-drug interactions in a cohort of hospitalized elderly patients. 105
Aging with multimorbidity: A systematic review of the literature. 104
Adverse Clinical Events and Mortality During Hospitalization and 3 Months After Discharge in Cognitively Impaired Elderly Patients. 104
An international perspective on chronic multimorbidity: approaching the elephant in the room 104
Need for De-Prescribing in Hospital Elderly Patients Discharged with Limited Life Expectancy: The REPOSI Study 104
Microvascular head and neck reconstruction in the elderly: The University of Brescia experience 103
Prescription drug use among older adults in Italy: A country-wide perspective 103
Prevalence of older in-patients at risk of clopidogrel resistance according to the STIB score. Results from REPOSI registry 103
Co-occurrence of cognitive impairment and physical frailty, and incidence of dementia: systematic review and meta-analysis 103
The relationship between chronic obstructive pulmonary disease and frailty: a systematic review and meta-analysis of observational studies 103
Scaling up health knowledge at European level requires sharing integrated data: An approach for collection of database specification 102
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 101
Time to face the challenge of multimorbidity. A European perspective from the joint action on chronic diseases and promoting healthy ageing across the life cycle (JA-CHRODIS) 101
Antipsychotic prescription and mortality in hospitalized older persons 101
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 100
Comparing the prognostic value of geriatric health indicators: a population-based study 100
A Multicomponent Intervention to Optimize Psychotropic Drug Prescription in Elderly Nursing Home Residents: An Italian Multicenter, Prospective, Pilot Study 99
The Impact of Frailty and Comorbidity on Institutionalization and Mortality in Persons With Dementia: A Prospective Cohort Study 99
Hypertension and frailty: A systematic review and meta-analysis 99
Walking Speed Drives the Prognosis of Older Adults with Cardiovascular and Neuropsychiatric Multimorbidity 99
Changes in trend of antipsychotics prescription in patients treated with cholinesterase inhibitors after warnings from italian Medicines Agency. results from the EPIFARM-Elderly Project. 98
Gender differences in disease distribution and outcome in hospitalized elderly: data from the REPOSI study 98
Potentially Inappropriate Drug Prescribing and the "never Change a Winning Team" Principle 98
Delirium, dementia and in-hospital mortality: the results from the Italian Delirium Day 2016, a national multicenter study 98
Comparison of disease clusters in two elderly populations hospitalized in 2008 and 2010. 97
The era of aging children and elderly parents: something new in emotional epidemiology 95
Atrial fibrillation, stroke and dementia in the very old: A population-based study 94
Total lymphocyte count and in-hospital mortality in older persons with multimorbidity 94
Hearing loss and cognitive decline in older adults: Questions and answers 94
Comorbidity and progression of late onset Alzheimer's disease: A systematic review 94
Target Population for Clinical Trials on Multimorbidity: Is Disease Count Enough? 94
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study. 93
Guidelines, polypharmacy, and drug-drug interactions in patients with multimorbidity 93
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 93
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 93
Effectiveness of an intervention for improving drug prescription in primary care patients with multimorbidity and polypharmacy: Study protocol of a cluster randomized clinical trial (Multi-PAP project) 93
Understanding adverse drug reactions in older adults through drug-drug interactions 93
Association between clusters of diseases and polypharmacy in hospitalized elderly patients: results from the REPOSI study. 92
Predictors of survival within 2 years of inpatient rehabilitation among older adults 92
Defining Health Trajectories in Older Adults With Five Clinical Indicators 91
Depression and heart failure: An intricate relationship 91
Disease clusters in older adults: rationale and need for investigation. 90
Assessing and Measuring Chronic Multimorbidity in the Older Population: A Proposal for Its Operationalization 90
Association Between Speed of Multimorbidity Accumulation in Old Age and Life Experiences: A Cohort Study 90
Prevalence and appropriateness of drug prescriptions for peptic ulcer and gastro-esophageal reflux disease in a cohort of hospitalized elderly. 89
Guidelines for elderly patients with multimorbidity: how to cope with a dark night without fear. 89
Age-related variation in health status after age 60 89
Best Practices for Drug Prescribing in Older Adults: A Call for Action 88
Frailty and multimorbidity: a systematic review and meta-analysis 88
Antipsychotics prescription and cerebrovascular events in Italian older persons 87
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: Results from the REPOSI Study 87
Patterns of comorbidity and multimorbidity in the oldest old: The Octabaix study 87
Differences in neuropsychological profile between healthy and COPD older persons. 86
Incidence and predictors of multimorbidity in the elderly: A population-based longitudinal study 86
Frailty: The pleasure and pain of geriatric medicine 86
The Relationship Between Anaemia and Frailty: A Systematic Review and Meta-Analysis of Observational Studies 86
Social contexts and cognition in the elderly: the case of Brescia 86
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity. 85
Agreement between fecal occult blood test and virtual colonoscopy in the diagnostic procedure of anemia in elderly patients 85
Clinical progression of dementia is worsened and accelerated by multimorbidity in a population-based study. 84
The Drug Prescription Network: A System-Level View of Drug Co-Prescription in Community-Dwelling Elderly People 84
Chronic diseases and geriatric syndromes: The different weight of comorbidity 84
Combining Gait Speed and Recall Memory to Predict Survival in Late Life: Population-Based Study 84
Interventional tools to improve medication adherence: Review of literature 84
Patterns of Multimorbidity in a Population-Based Cohort of Older People: Sociodemographic, Lifestyle, and Functional Differences 84
Clinical Severity, Age, and Sex Overcome Cardiometabolic Morbidities but Not Stroke as Predictors of Mortality in Elderly Inpatients: Data From the REgistro POliterapie Società Italiana di Medicina Interna Registry 84
In-hospital death according to dementia diagnosis in acutely ill elderly patients: the REPOSI Study 83
Reply to: Function but not Multimorbidity at the Cornerstone of Geriatric Medicine 83
Hospital admissions for acute onset of behavioral symptoms in demented patients: what do they want to say? 82
Emerging changes in the care of older people 82
Factors affecting adherence to guidelines for antithrombotic therapy in elderly patients with atrial fibrillation admitted to internal medicine wards. 82
The influence of multimorbidity on clinical progression of dementia in a population-based cohort. 82
Multimorbidity care model: Recommendations from the consensus meeting of the Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) 82
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 82
EuGMS Task and Finish group on Fall-Risk-Increasing Drugs (FRIDs): Position on Knowledge Dissemination, Management, and Future Research 82
Socioeconomic status during lifetime and cognitive impairment no-dementia in late life: the population-based aging in the Chianti Area (InCHIANTI) Study. 82
Prevalence and characteristics of antidepressant drug prescriptions in older Italian patients. 81
Totale 10.323
Categoria #
all - tutte 85.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 85.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.937 790 147 158 599 320 589 474 553 369 529 130 279
2020/20213.380 54 413 149 376 174 408 166 419 405 383 314 119
2021/20221.730 113 286 47 104 10 60 93 177 119 176 129 416
2022/20231.390 270 18 27 85 119 395 6 127 179 17 66 81
2023/20241.521 80 43 112 109 50 234 38 34 493 25 23 280
2024/202551 51 0 0 0 0 0 0 0 0 0 0 0
Totale 17.150